USANA Health Sciences, Inc. (USNA)

NYSE: USNA · USD

$14.6

+0.52 (+3.7%)· Recorded snapshot

Market cap	269.6M
Revenue (ttm)	913.4M
Net income (ttm)	-22.2M
EPS (ttm)	-$1.21
Shares out	18.5M
P/E (forward)	13.8x
Volume	127,019
Beta	0.68

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 913.4M
Net income (ttm): -22.2M
EPS (ttm): -$1.21
P/E (forward): 13.8x
Market cap: 269.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ADM	Archer-Daniels-Midland Company	37.3B	21.2x	0.5x	5.0%	+1.8%	+28.5%	Giảm
BF.B	Brown-Forman Corporation Class B	12.7B	17.9x	3.3x	14.3%	+1.6%	+0.4%	Mua
CAG	Conagra Brands, Inc.	6.6B	—	0.6x	9.2%	+0.2%	-18.9%	Mua mạnh

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E13.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-5.1

P25 n/aP50 n/aP75 n/a

ROIC-112.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All USNA indicators

Market & fundamental data

Available fields

256

Groups with data

Currency

USD

Showing 256 of 256 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000896264
Company name	USANA Health Sciences, Inc.
Country	United States
Country code	US
CUSIP number	90328M107
Earnings date	2026-11-03
Earnings time	amc
Employees	1,570
Employees change	-130
Employees growth	-7.65%
Enterprise value	$101M
Exchange	NYSE
Financial currency	USD
Financial report date	2026-07-04
First seen	2026-05-09
Fiscal year end	January
Founded	1992
In index	RUSSELL2000
Industry	Packaged Foods
IPO date	1996-07-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US90328M1071
Last 10-K release date	2026-03-16
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2016-11-23
Last stock split type	Forward
Market cap	$269.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$14.59
Price currency	USD
Sector	Consumer Staples
SIC code	2833
Stock price date	2026-10-28
Symbol	USNA
U.S. state	Utah
Website	https://www.usana.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	14.74x
Average P/E ratio (10Y)	18.63x
Average P/E ratio (3Y)	20.55x
Average P/E ratio (5Y)	18.61x
Earnings yield	-8.27%
EV/EBIT	2.36x
EV/EBITDA	1.33x
EV/FCF	6.15x
EV/Sales	0.11x
FCF / EV yield	16.25%
FCF yield	5.98%
Forward EV/Sales	0.11x
Forward P/E	13.79x
Forward P/S	0.29x
Industry forward P/E	12.41x
Industry P/E	68.48x
P/(FCF - SBC) ratio	152.35x
P/(OCF - SBC) ratio	19.69x
P/B ratio	0.49x
P/FCF ratio	16.73x
P/OCF ratio	9.62x
P/S ratio	0.29x
PEG ratio	1.15x
Price / tangible book value	0.91x
Price/EBITDA ratio	3.61x
Sector forward P/E	21.27x
Sector P/E	28.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.54%
EBITDA margin	8.09%
Effective tax rate	1,253.35%
FCF margin	1.74%
Gross margin	77.45%
Operating margin	4.54%
Pretax margin	0.28%
Profit margin	-2.43%
Profit per employee	$-14,117
Profitable years	32
Revenue per employee	$581,759
ROA	3.61%
ROA (5Y)	9.88%
ROCE	6.94%
ROE	-5.06%
ROE (5Y)	13.6%
ROIC	-112.8%
ROIC (5Y)	32.66%
SBC / revenue	1.55%
Tax / revenue	3.48%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth	-68.75%
FCF growth (Q)	180.41%
FCF growth (QoQ)	183.44%
FCF growth 3Y	-41.45%
FCF growth 5Y	-36%
Gross profit growth	-1.59%
Gross profit growth (Q)	-5.78%
Gross profit growth 3Y	-2.49%
Gross profit growth 5Y	-7.13%
Net income growth years	0
OCF growth	-56%
OCF growth (Q)	90.86%
OCF growth (QoQ)	138.95%
OCF growth 10Y	-13.13%
OCF growth 3Y	-32.95%
OCF growth 5Y	-29.19%
Operating income growth	-35.62%
Operating income growth (Q)	-45.32%
Operating income growth 3Y	-24.51%
Operating income growth 5Y	-26.68%
Revenue growth	1.57%
Revenue growth (Q)	-5.33%
Revenue growth (QoQ)	-10.77%
Revenue growth 10Y	-0.55%
Revenue growth 3Y	-1.23%
Revenue growth 5Y	-6.14%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-11.8M
Depreciation and amortization	$32.4M
EBIT	$41.5M
EBITDA	$73.9M
EPS	$-1.21
FCF per share	$0.86
Financing cash flow	$-5.2M
Free cash flow	$15.9M
Free cash flow minus SBC	$1.8M
Gross profit	$707.4M
Income taxes	$31.8M
Investing cash flow	$-8.7M
Net cash flow	$17.4M
Net income	$-22.2M
Operating cash flow minus SBC	$13.5M
Operating income	$41.5M
Revenue	$913.4M
Stock-based compensation	$14.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.58
Book value per share	$28.51
Debt / equity	0
Goodwill	$109.1M
Interest coverage	100.7
Long-term assets	$422.1M
Long-term liabilities	$26.6M
Net cash (debt)	$168.6M
Net cash / market cap	63.22%
Net cash growth	11.38%
Net debt / EBITDA	-2.28
Net debt / equity	-0.3
Net debt / FCF	-10.58
Piotroski F-Score	4
Property, plant and equipment	$94.3M
Shareholders' equity	$571M
Tangible book value	$292.6M
Tangible book value per share	$15.85
Total assets	$703.2M
Total cash	$168.6M
Total debt	$0
Total liabilities	$132.2M
WACC	8%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.27
Current assets	$281.1M
Current liabilities	$105.7M
Current ratio	2.66
Inventory turnover	2.43
Net working capital	$6.8M
Quick ratio	1.63
Working capital	$175.4M
Working capital turnover	5.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.1%
Dividend yield	0%
Shareholder yield	3.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-77.23%
10Y return CAGR	-13.76%
10Y total return	-77.23%
150-day SMA	$17.53
15Y price change	-13.9%
15Y return CAGR	-0.99%
15Y total return	-13.9%
1D price change	3.7%
1M price change	0.62%
1M total return	0.62%
1W price change	2.6%
1W total return	2.6%
1Y price change	-27.41%
1Y return CAGR	-27.43%
1Y total return	-27.41%
20-day SMA	$14.72
200-day SMA	$18.17
20Y price change	-34.71%
20Y return CAGR	-2.11%
20Y total return	-34.71%
3M price change	-34.69%
3M total return	-34.69%
3Y price change	-67.51%
3Y return CAGR	-31.25%
3Y total return	-67.51%
50-day SMA	$14.51
50-day SMA vs 200-day SMA	50under200
52-week high	$23.59
52-week high date	2026-07-28
52-week low	$12.57
52-week low date	2026-08-18
5Y price change	-84.22%
5Y return CAGR	-30.88%
5Y total return	-84.22%
6M price change	-24.72%
6M total return	-24.72%
All-time high	$137.95
All-time high date	2018-07-25
All-time low	$0.22
All-time low date	2000-12-26
Average true range (ATR)	$0.62
Average volume	172.9K
Beta (1Y)	0.16
Beta (2Y)	0.85
Beta (5Y)	0.68
Change from 52-week high	-38.15%
Change from 52-week low	16.07%
Change from all-time high	-89.42%
Change from all-time low	6,568.19%
Change from open	4.51%
Day's gap	-0.78%
Dollar volume	$1.9M
High price	$14.66
Low price	$13.96
Monthly RSI	30.59
Open price	$13.96
Position in 52-week range	90%
Premarket change	-0.36%
Premarket close	$14.07
Premarket price	$14.02
Previous close	$14.07
Price vs 150-day SMA	-16.79%
Price vs 20-day SMA	-0.91%
Price vs 200-day SMA	-19.69%
Price vs 50-day SMA	0.57%
Relative volume	0.75
RSI	48.72
Sharpe ratio	-0.37
Sharpe ratio (3Y)	-0.78
Sharpe ratio (5Y)	-0.83
Sortino ratio	-0.35
Sortino ratio (3Y)	-0.85
Sortino ratio (5Y)	-0.91
Volume	127K
Weekly RSI	40.6
YTD price change	-25.67%
YTD total return	-25.67%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9.9M
Float percentage	53.69%
Shares change (QoQ)	0.41%
Shares change (YoY)	-3.1%
Shares held by insiders	41.01%
Shares held by institutions	57.39%
Shares outstanding	18.5M
Short % of float	7.78%
Short % of shares	4.18%
Short ratio	3.7 days

Deeper analysis on USNA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this USNA report

Is a complete USNA research report available?

No complete published report is available for USANA Health Sciences, Inc. (USNA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

USANA Health Sciences, Inc. (USNA)

Price

Financial snapshot

Fair-value bridge

Latest news · USNA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All USNA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on USNA

Frequently asked questions